CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 4 Option exercise 10% owner acquired 3,333 shares (option exercise)
- 4 Open-market buy 10% owner bought 1,290,212 shares at an average $4.06 ($5,242,308)
- 4 Open-market buy 10% owner bought 72,429 shares at an average $4.03 ($291,927)
- 4 Open-market buy 10% owner bought 139,700 shares at an average $4.05 ($566,178)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 4,333 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 7,500 shares at $4.16 ($31,193)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion SVP, Preclinical Research acquired 15,938 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 22 of 37 · 739 filings